A Closer Look: Changes To China’s Orthopedics Market Fuel Deals Like Stryker-Trauson
This article was originally published in PharmAsia News
Large domestic players like Trauson could benefit from new guidelines mandating centralized purchases for high-value medical consumables.
You may also be interested in...
Medical Device Companies Come Up With Creative Solutions To Increase Access To Rural Communities In Asia
HONG KONG - A little less than two years ago, multinational conglomerate GE Healthcare said it would spend up to $6 billion in healthcare innovation through a program dubbed "Healthymagination.
Facing Tougher Competition At Home, China's Mindray Should Target Global Mid- To High-end Market, Analysts Say
Facing a new round of marketing campaigns from international device makers targeting China's low- to mid-end hospital markets, Shenzhen based Mindray Medical will be better off focusing instead on mid- to high-end global markets to stay competitive, analysts say
U.S.-listed orthopedic device maker Zimmer Inc. says its latest overseas purchase of Beijing Montagne Medical Device Co. Ltd., gives it greater marketing access to the Chinese orthopedic implant market, growing at an estimated 15 percent annually, and a manufacturing base to compete with rivals already in the market